Alnylam Pharmaceuticals (ALNY) Amortization of Deferred Charges (2019 - 2024)
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Amortization of Deferred Charges (2019 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 13.06 Mn |
| Jun 30, 2024 | 9.69 Mn |
| Mar 31, 2024 | 11.97 Mn |
| Dec 31, 2023 | 10.49 Mn |
| Sep 30, 2023 | 10.20 Mn |
| Jun 30, 2023 | 10.27 Mn |
| Mar 31, 2023 | 12.01 Mn |
| Dec 31, 2022 | 10.57 Mn |
| Sep 30, 2022 | 10.05 Mn |
| Jun 30, 2022 | 10.14 Mn |
| Mar 31, 2022 | 10.32 Mn |
| Dec 31, 2021 | 10.08 Mn |
| Sep 30, 2021 | 11.43 Mn |
| Jun 30, 2021 | 10.36 Mn |
| Mar 31, 2021 | 10.26 Mn |
| Dec 31, 2020 | 10.49 Mn |
| Sep 30, 2020 | 10.20 Mn |
| Jun 30, 2020 | 9.58 Mn |
| Mar 31, 2020 | 9.39 Mn |
| Dec 31, 2019 | 9.32 Mn |